Another recent study that showed that the rate of cognitive decline in AD patients with diabetes was significantly less than those without appeared to conflict with the previous study, however the patients with diabetes were being treated with insulin and/or anti-diabetic medication (though the percentages were not reported) [159], so the findings of both papers that diabetic/insulin medication is useful for treating AD cognitive decline may be similar. This evidence concerns the gene INS and diabetes mellitus.